Yong Qing Luo

Yong Qing Luo

Chief Executive Officer at EVEREST MEDICINES LIMITED

Net worth: 7 M $ as of 2026-08-30

56 year
Health Technology
Consumer Services

Profile

Yong Qing Luo currently works at Everest Medicines Ltd., as Chief Executive Officer & Executive Director from 2022 and Tengsheng Boyao Pharmaceutical Technology Shanghai Co., Ltd., as President & General Manager from 2020.
Dr. Luo also formerly worked at Novartis AG, as Associate Brand Director from 2007 to 2009, Brii Biosciences Ltd. (China), as President, Executive Director & GM-Greater China from 2021 to 2022, Beijing Novartis Pharma Co. Ltd., as Head-Great China Pharmaceutical Organization from 2009 to 2012, Shanghai Roche Pharmaceuticals Ltd., as Vice President from 2012 to 2016, and Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd., as Global Vice President & General Manager-China from 2016 to 2020.
Dr. Luo received his Masters Business Admin degree in 2006 from China Europe International Business School and doctorate degree in 1992 from Xiangya School of Medicine.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-06-29 1,772,397 ( 0.5% ) 7 M $ 2026-08-30

Yong Qing Luo active positions

CompaniesPositionStart
EVEREST MEDICINES LIMITED Chief Executive Officer 2022-09-18
President 2020-09-16

Former positions of Yong Qing Luo

CompaniesPositionEnd
BRII BIOSCIENCES LIMITED President 2022-09-14
Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd.
Corporate Officer/Principal 2020-08-31
Corporate Officer/Principal 2016-07-31
Corporate Officer/Principal 2012-07-31
NOVARTIS AG Corporate Officer/Principal 2009-05-31
See the detail of Yong Qing Luo's experience

Training of Yong Qing Luo

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Gilead Sciences Shanghai Pharmaceutical Technology Co. Ltd.

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!